GlassScriptPhysician profile
Lauren E Sheehan
NPI 1225752090
$1,107.28
in general payments reported to CMS, 2019-2025
13 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $435 · 2024: $481 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $153.92 | 2024 | Daybue |
| Alk-Abello, INC | $153.25 | 2024 | Grastek, Ragwitek, Odactra |
| Alexion Pharmaceuticals, INC. | $124.99 | 2023 | |
| Sanofi-Aventis U.S. LLC | $124.99 | 2023 | |
| Merck Sharp & Dohme LLC | $123.44 | 2023-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Seqirus USA INC | $110.30 | 2023-2025 | Flucelvax |
| Cumberland Pharmaceuticals, INC. | $103.55 | 2024-2025 | Kristalose |
| Ironshore Pharmaceuticals INC. | $77.05 | 2023 | Jornay Pm |
| Cranial Technologies, INC | $37.27 | 2025 | Doc Band |
| Corium, LLC | $32.92 | 2025 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $30.33 | 2024 | Flumist Quadrivalent |
| Pfizer INC. | $18.45 | 2024 | |
| Glaxosmithkline, LLC. | $16.82 | 2025 | Bexsero, Penmenvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.